A carregar...
Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?
The blood–retinal barrier (BRB) alteration is the hallmark feature of diabetic retinopathy. Vascular endothelial growth factor (VEGF) is a potent vasopermeability factor that has been implicated in the pathogenesis of BRB alteration. Inflammation also plays a crucial role in this process with involv...
Na minha lista:
Publicado no: | Indian J Ophthalmol |
---|---|
Main Authors: | , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Medknow Publications & Media Pvt Ltd
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4821120/ https://ncbi.nlm.nih.gov/pubmed/26953018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0301-4738.178154 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|